Ginkgo Bioworks, alongside Tangible Scientific and Inductive Bio, launches ADME-One™, an advanced platform enhancing drug discovery by integrating ADME data and AI projections, optimizing early-stage decision making.

Inductive has launched Beacon-2, a pioneering system enhancing the ability to predict human dosages of small molecules. This innovation aims to streamline drug discovery processes.

Inductive Bio unveils Indy, an AI chemistry assistant that promises to enhance medicinal chemists' efficiency, doubling productivity and streamlining drug development.

Inductive Bio has clinched its third consecutive victory in the AI drug discovery arena, establishing itself as a leading force in the pharmaceutical industry. Discover more about their recent achievement.

Inductive Bio partners with Anthropic to streamline drug discovery, enabling scientists to access advanced ADMET prediction models through the Claude interface, enhancing research efficiencies.

Inductive Bio has emerged victorious in the OpenADMET-ExpansionRx challenge, showcasing advanced AI technology for drug discovery. This win represents a significant step in enhancing real-world drug development practices.

Inductive Bio has received a significant funding award to develop AI models focused on drug toxicity, enhancing drug safety assessments and reducing animal testing dependency.

Ginkgo Bioworks, Inductive Bio, and Tangible Scientific join forces to integrate AI for enhanced drug discovery, streamlining logistics and boosting efficiency.